{"symbol":"ABBV","fiscalQuarter":"Q3-2021","reportDate":"2021-10-29","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2021","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 4.56%","keyNumbers":[{"metric":"EPS","actual":"$3.33","expected":"N/A","surprise":"+3.26%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Confident","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","They highlighted ongoing strength in their product portfolio."],"summary":"Overall, management conveyed confidence in the company's current trajectory. They noted strong performance in key areas, although no specific revenue guidance was provided."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"AbbVie's earnings report shows that the company performed well on EPS, exceeding expectations. The positive stock reaction of 4.56% suggests that investors are pleased with the results, particularly in light of the strong EPS performance. However, the lack of revenue figures and guidance may leave some uncertainty about future performance.","metaDescription":"AbbVie (ABBV) Q3 2021 earnings: EPS beat by 3.26%. Stock up 4.56%. Full breakdown."}}